Table 1.
Patient Characteristics
| Characteristics | Non- recurrent n=8 | Recurrent n = 18 | P-value* |
|---|---|---|---|
|
| |||
| Age at initial diagnosis | 41.5 ± 11.3 | 41.7 ± 13.6 | 0.87 |
|
| |||
| Age at transplant | 52.5 ± 10.5 | 51.3 ± 11.1 | 0.80 |
|
| |||
| Sex (no, % male) | 6(75%) | 11(61%) | 0.67 |
|
| |||
| Race (no, % Caucasian) | 8(100%) | 15(83%) | 0.53 |
|
| |||
| Donor type (no, %) | |||
| Living Related Donor | 3(37.5%) | 10(56%) | 0.135 |
| Living Unrelated Donor | 1(12.5%) | 6(33%) | |
| Cadaveric Donor | 4(50%) | 2(11%) | |
|
| |||
| Biopsy-proven MN in native kidney (no, %) | 8(100%) | 16(89%) | 1.0 |
|
| |||
| Prior transplants (no, %) | 0 | 4(22%) | 0.28 |
|
| |||
| Standard triple immunosuppressant therapy (no, %) | 6(75%) | 15(83%) | 0.63 |
|
| |||
| Induction with Thymoglobulin (no, %) | 6(75%) | 14(77%) | 1.0 |
• Mean ± standard deviation unless otherwise indicated.
*
Comparisons in baseline characteristics were performed by unpaired t-test, two tailed U test (Mann–Whitney) or Wilcoxon signed-rank test for continuous variables and Fisher’s exact test for binary variables.